miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome

Frontiers in Genetics

Volumn 3, Issue DEC, 2012, Pages

  Brzustowicz, Linda M ^a,b   Bassett, Anne S ^c,d,e  

^a RUTGERS UNIVERSITY   (United States)

^b Life Sciences Building Rutgers University   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Copy number variation; DGCR8; Genetic; miRNA; Schizophrenia

Indexed keywords

EID: 84876088727     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00291     Document Type: Article

References (49)

1. Babiarz, J. E., Hsu, R., Melton, C., Thomas, M., Ullian, E. M., and Blelloch, R. (2011). A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing. RNA 17, 1489-1501.
2. Babiarz, J. E., Ruby, J. G., Wang, Y., Bartel, D. P., and Blelloch, R. (2008). Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. 22, 2773-2785.
3. Barr, I., Smith, A. T., Chen, Y., Senturia, R.,Burstyn,J.N.,andGuo,F. (2012). Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for primary microRNA processing. Proc. Natl. Acad. Sci. U.S.A. 109, 1919-1924.
4. Bartlett, C. W., and Vieland, V. J. (2007). Accumulating quan- titative trait linkage evidence across multiple datasets using the posterior probability of linkage. Genet. Epidemiol. 31, 91-102.
5. Bassett, A. S., Caluseriu, O., Weksberg, R.,Young,D.A.,andChow,E.W. (2007). Catechol-O-methyl trans- ferase and expression of schizophre- nia in 73 adults with 22q11 dele- tion syndrome. Biol. Psychiatry 61, 1135-1140.
6. Bassett, A. S., and Chow, E. W. (2008). Schizophrenia and 22q11.2 deletion syndrome. Curr.PsychiatryRep.10, 148-157.
7. Bassett, A. S., McDonald-McGinn, D. M., Devriendt, K., Digilio, M. C., Goldenberg, P., Habel, A., et al. (2011). Practical guidelines for managing patients with 22q11.2 deletion syndrome. J. Pediatr. 159, 332-339 e331.
8. Beveridge, N. J., and Cairns, M. J. (2012). MicroRNA dysregulation in schizophrenia. Neurobiol. Dis. 46, 263-271.
9. Biggar, R. J., Cassol, S., Kumwenda, N., Lema, V., Janes, M., Pilon, R., et al. (2003). The risk of human immun- odeficiency virus-1 infection in twin pairs born to infected mothers in Africa. J. Infect. Dis. 188, 850-855.
10. Chi, S. W., Zang, J. B., Mele, A., and Darnell, R. B. (2009). Argonaute HITS-CLIP decodes microRNA- mRNA interaction maps. Nature 460, 479-486.
11. Driscoll, D. A., Salvin, J., Sellinger, B., Budarf, M. L., McDonald-McGinn, D. M., Zackai, E. H., et al. (1993). Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J. Med. Genet. 30, 813-817.
12. Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011). miRWalk- database: prediction of possible miRNA binding sites by "walk- ing" the genes of three genomes. J. Biomed. Inform. 44, 839-847.
13. Edelmann, L., Pandita, R. K., and Morrow, B. E. (1999). Low-copy repeats mediate the common 3- Mb deletion in patients with velo- cardio-facial syndrome. Am. J. Hum. Genet. 64, 1076-1086.
14. Fujita, P. A., Rhead, B., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Cline, M. S., et al. (2011). The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876-D882.
15. Fung,W.L.,McEvilly,R.,Fong,J., Silversides, C., Chow, E., and Bassett, A. (2010). Elevated preva- lence of generalized anxiety disorder in adults with 22q11.2 deletion syn- drome. Am. J. Psychiatry 167, 998.
16. Goodship, J., Cross, I., Liling, J., and Wren, C. (1998). A population study of chromosome 22q11 dele- tions in infancy. Arch. Dis. Child. 79, 348-351.
17. Guo, T., McDonald-McGinn, D., Blonska, A., Shanske, A., Bassett, A. S., Chow, E., et al. (2011). Genotype and cardiovascular phenotype correlations with TBX1 in 1, 022 velo-cardio- facial/DiGeorge/22q11.2 deletion syndrome patients. Hum. Mutat. 32, 1278-1289.
18. Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., et al. (2010). Transcriptome-wide identifica- tion of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141.
19. Hornstein, E., and Shomron, N. (2006). Canalization of development by microRNAs. Nat. Genet. 38(Suppl.), S20-S24.
20. Huang, J., and Vieland, V. J. (2001). Comparison of 'model-free' and 'model-based' linkage statistics in the presence of locus heterogene- ity: single data set and multiple data set applications. Hum. Hered. 51, 217-225.
21. Huang, Y., Bartlett, C. W., Segre, A. M., O'Connell, J. R., Mangin, L., and Vieland, V. J. (2007). Exploiting gene x gene interaction in linkage analysis. BMC Proc. 1(Suppl. 1):S64.
22. Huang, Y., and Vieland, V. J. (2010). Association statistics under the PPL framework. Genet. Epidemiol. 34, 835-845.
23. Insel, T. R. (2010). Rethinking schizophrenia. Nature 468, 187-193.
24. Kent,W.J.,Sugnet,C.W.,Furey,T.S., Roskin, K. M., Pringle, T. H., Zahler, A. M., et al. (2002). The human genome browser at UCSC. Genome Res. 12, 996-1006.
25. Kim,A.H.,Parker,E.K.,Williamson, V.,McMichael,G.O.,Fanous,A. H., and Vladimirov, V. I. (2012). Experimental validation of candi- date schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr. Res. 141, 60-64.
26. Kleinjan, D.-J., and Coutinho, P. (2009). Cis-ruption mechanisms: disruption of cis-regulatory control as a cause of human genetic disease. Brief. Funct. Genomic. Proteomic. 8, 317-332.
27. Kumar, D. (2008). Disorders of the genome architecture: a review. Genomic. Med. 2, 69-76.
28. Kwon, E., Wang, W., and Tsai, L. H. (2011). Validation of schizophrenia- associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR- 137 targets. Mol. Psychiatry.doi: 10.1038/mp.2011.170. [Epub ahead of print].
29. Lander, E. S., Linton, L. M., Birren, B.,Nusbaum,C.,Zody,M.C., Baldwin, J., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
30. Linder, C. C. (2006). Genetic variables that influence phenotype. ILAR J. 47, 132-140.
31. Logue, M. W., George, A. W., Spence, M. A., and Vieland, V. J. (2005). Performance comparison of two- point linkage methods using microsatellite markers flanking known disease locations. BMC Genet. 6(Suppl. 1):S141. doi: 10.1186/1471-2156-6-S1-S141
32. Meechan, D. W., Maynard, T. M., Tucker, E. S., and Lamantia, A. S. (2011). Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain devel- opment: patterning, proliferation, and mitochondrial functions of 22q11 genes. Int. J. Dev. Neurosci. 29, 283-294.
33. Mellios, N., and Sur, M. (2012). The emerging role of microRNAs in schizophrenia and autism spectrum disorders. Front Psychiatry 3:39. doi: 10.3389/fpsyt.2012.00039
34. Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., and Brzustowicz, L. M. (2011). Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69, 188-193.
35. Ripke, S., Sanders, A. R., Kendler, K. S., Levinson, D. F., Sklar, P., Holmans, P. A., et al. (2011). Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976.
36. Royall, R. (1997). Statistical Evidence: A Likelihood Paradigm.London: Chapman and Hall.
37. Saito, Y., and Saito, H. (2012). MicroRNAs in cancers and neu- rodegenerative disorders. Front. Gene. 3:194. doi: 10.3389/ fgene.2012.00194
38. Shaikh, T. H., Kurahashi, H., Saitta, S. C., O'Hare, A. M., Hu, P., Roe, B. A., et al. (2000). Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum. Mol. Genet. 9, 489-501.
39. Stark, K. L., Xu, B., Bagchi, A., Lai, W.-S., Liu, H., Hsu, R., et al. (2008). Altered brain microRNA biogenesis contributes to pheno- typic deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751-760.
40. Vieland, V. J. (2006). Thermometers: something for statistical geneticists to think about. Hum. Hered. 61, 144-156.
41. Vieland, V. J., Hallmayer, J., Huang, Y., Pagnamenta, A. T., Pinto, D., Khan, H., et al. (2011a). Novel method for combined linkage and genome-wide association analysis finds evidence of distinct genetic architecture for two subtypes of autism. J. Neurodev. Disord. 3, 113-123.
42. Vieland, V. J., and Hodge, S. E. (1998). Reveiw of statistical evidence: a likelihood paradigm. Am. J. Hum. Genet. 63, 283-289.
43. Vieland, V. J., Huang, Y., Seok, S. C., Burian, J., Catalyurek, U., O'Connell, J., et al. (2011b). KELVIN: a software package for rigorous measurement of statistical evidence in human genetics. Hum. Hered. 72, 276-288.
44. Vieland, V. J., Wang, K., and Huang, J. (2001). Power to detect link- age based on multiple sets of data in the presence of locus heterogeneity: comparative evaluation of model-based linkage methods for affected sib pair data. Hum. Hered. 51, 199-208.
45. Vorstman,J.A.,Chow,E.W.,Ophoff, R. A., Van Engeland, H., Beemer, F. A., Kahn, R. S., et al. (2009). Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 430-433.
46. Xu, B., Roos, J. L., Levy, S., Van Rensburg,E.J.,Gogos,J.A.,and Karayiorgou, M. (2008). Strong association of de novo copy num- ber mutations with sporadic schizophrenia. Nat. Genet. 40, 880-885.
47. Yang, J. H., Li, J. H., Shao, P., Zhou, H.,Chen,Y.Q.,andQu,L.H. (2011). starBase: a database for exploring microRNA-mRNA inter- action maps from Argonaute CLIP-Seq and Degradome- Seq data. Nucleic Acids Res. 39, D202-D209.
48. Zhang,F.,Chen,Y.,Liu,C.,Lu,T., Yan, H., Ruan, Y., et al. (2012). Systematic association analysis of microRNA machinery genes with schizophrenia informs fur- ther study. Neurosci. Lett. 520, 47-50.
49. Zisoulis, D. G., Lovci, M. T., Wilbert, M.L.,Hutt,K.R.,Liang,T. Y., Pasquinelli, A. E., et al. (2010). Comprehensive discov- ery of endogenous Argonaute binding sites in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 17, 173-179.